Gut microbial signatures and immunotherapy outcomes in NSCLC and melanoma: a systematic review and meta-analysis

Abstract Background The composition of the gut microbiome has been linked to clinical responses to immune checkpoint inhibitors (ICIs), but its prognostic association with outcomes in non-small cell lung cancer (NSCLC) and melanoma remains incompletely defined. We performed a systematic review and m...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mohammed Elmujtba Adam Essa, Hamid Noori, James Butler, Abdelkareem A. Ahmed
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2026-02-01
Serie:	BMC Cancer
Soggetti:	gut microbiome immune checkpoint inhibitors NSCLC melanoma Akkermansia Faecalibacterium
Accesso online:	https://doi.org/10.1186/s12885-026-15763-3
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!